Clinical Trial of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine
NCT01263327
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Cervical Cancer
Interventions
BIOLOGICAL:
HPV 16/18
Sponsor
Xiamen University
Collaborators
[object Object]
[object Object]